Kiniksa Pharmaceuticals, Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
94.98 | 48.72 | 94.95% | 18.76 | +406.3% |
| P/S |
|
4.95 | 33.75 | -85.33% |
|
|
| P/BV |
|
3.05 | 4.82 | -36.72% |
|
|
| P/FCF |
|
89.59 | 61 | 46.87% |
|
|
| Ev/Ebitda |
|
-53.8 | -22.17 | 142.65% |
|
|
| Ev/S |
|
4.6 | 22.56 | -79.63% |
|
|
| Ev/FCF |
|
94.3 | 68.75 | 37.17% |
|
|
| E/P |
|
0.0119 | 0.0178 | -33.05% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-8.54 | 4.98 | -271.64% | -730.61 | -98.83% |
| ROE |
|
3.21 | 9.61 | -66.61% |
|
|
| ROA |
|
2.68 | 0.3443 | 677.3% |
|
|
| ROIC |
|
-59.58 | 7.63 | -880.42% |
|
|
| ROS |
|
5.21 | -25.17 | -120.7% |
|
|
| ROCE |
|
-5.74 | 15.35 | -137.4% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5309 | -3.68 | -85.56% | -0.2064 | +157.29% |
| Nеt Debt/Ebitda |
|
4.15 | -3.44 | -220.61% |
|
|
| Debt/Ratio |
|
0.0233 | 0.1985 | -88.27% |
|
|
| Debt/Equity |
|
7.21 | 1.66 | 333.79% |
|
|
| Debt/Net Income |
|
0.8703 | 10.32 | -91.57% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
3409.86 | -56.89 | -6093.78% | ||
| Growth impulse Ebitda in 5 years |
|
-85.88 | -54.68 | 57.06% | ||
| Growth impulse Net Income in 5 years |
|
-108.69 | -58.33 | 86.34% | ||
| Growth impulse FCF in 5 years |
|
-108.13 | -49.48 | 118.53% | ||
| Growth impulse EPS in 5 years |
|
-106.55 | -32.41 | 228.76% |
IP Score
2.6/10
